Australasia life sciences venture capital firm, Brandon Capital, has announced the final close of its sixth fund at A$439m (US$290m). Brandon BioCatalyst Fund Six (BB6) was launched in 2024 with…
Australia: Brandon Capital holds final close of Fund Six at A$439m
…
…






